Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Flying Brands subsidiary Imaging Biometrics inks neuroscience research partnership

Its software will be loaded to a cloud-based platform called QMENTA
medical image
As the name suggests Imaging Biometrics has developed imaging software. It is used by the medical community

Flying Brands Ltd (LON:FBDU) subsidiary, Imaging Biometrics (IB), said it has agreed a partnership which it reckons will "accelerate neuroscience research and increase accuracy in diagnostics support".

It hopes to do this by loading its software to a cloud-based platform called QMENTA, which provides data analysis and management for neuro experts.

IB's technology will be the first US Food & Drug Administration-cleared option on the system, which streamlines medical imaging workflow for running clinical trials. 

Four modules offered

Being offered are modules IB Neuro, IB Delta T1 Maps, IB Diffusion and IB DCE.

"Our partnership with QMENTA enables efficient and immediate access to our quantitative imaging solutions to those involved in clinical trials and research," said IB chief executive Michael Schmainda.

"It is exciting to be part of QMENTA's neuro-centric platform and helping advance the understanding of neurological disorders."

 

View full FBDU profile View Profile

Flying Brands Ltd Timeline

Related Articles

H&T Pawnbrokers store
November 15 2017
“We have delivered a strong trading performance during the second half in the key segments of Pawnbroking, Retail and Personal Loans”
Flying Brands
March 07 2018
Flying Brands has signed a deal for the sale and distribution of its StoneChecker software in South Korea

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use